Skip to content
Cohance Lifesciences
Cohance LifesciencesCohance Lifesciences
  • Home
  • About
    • Our Company
    • Vision and Values
    • Board of Directors, Management & Advisory Council
    • Corporate Information
  • Business Units
    • CDMO
    • API and Formulations
    • Clinical research & Bio Analytical Studies
  • Research and Development
  • Infrastructure
    • Overview
    • Manufacturing Units
      • API Unit I – Jaggayapet
      • API Unit II – Atchutapuram
      • API Unit III – Ankaleshwar
      • API Unit IV – Nacharam
      • API Unit V – Parwada, Vizag
      • FDF/PFI Unit I – Nacharam
      • FDF/PFI Unit II – Jadcherla
    • R&D
      • API R&D Unit I – Patancheru
      • API R&D Unit II – Ankaleshwar
      • API R&D Unit III – Nacharam
      • FDF R&D Unit I – Nacharam
    • Clinical Research and Bio Analytical Studies
      • CRBio – Balanagar
  • Sustainability
    • EHS
    • CSR
    • Governance
  • Life at Cohance
    • We are Cohancers
    • Cohance with Us
    • Gallery
  • Investors
  • Media
    • Press release/announcement
    • Media coverage
  • Contact
  • Home
  • About
    • Our Company
    • Vision and Values
    • Board of Directors, Management & Advisory Council
    • Corporate Information
  • Business Units
    • CDMO
    • API and Formulations
    • Clinical research & Bio Analytical Studies
  • Research and Development
  • Infrastructure
    • Overview
    • Manufacturing Units
      • API Unit I – Jaggayapet
      • API Unit II – Atchutapuram
      • API Unit III – Ankaleshwar
      • API Unit IV – Nacharam
      • API Unit V – Parwada, Vizag
      • FDF/PFI Unit I – Nacharam
      • FDF/PFI Unit II – Jadcherla
    • R&D
      • API R&D Unit I – Patancheru
      • API R&D Unit II – Ankaleshwar
      • API R&D Unit III – Nacharam
      • FDF R&D Unit I – Nacharam
    • Clinical Research and Bio Analytical Studies
      • CRBio – Balanagar
  • Sustainability
    • EHS
    • CSR
    • Governance
  • Life at Cohance
    • We are Cohancers
    • Cohance with Us
    • Gallery
  • Investors
  • Media
    • Press release/announcement
    • Media coverage
  • Contact

Daily Archives: November 3, 2022

You are here:
  1. Home
  2. 2022
  3. November
  4. 03

Advent International launches Cohance Lifesciences, a new brand identity for its API platform

Press release/announcementBy cohanceNovember 3, 2022

Press Release API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories The platform hopes to add more assets in the future and aims to be a top three merchant API and CDMO company in India Mumbai, November 1, 2022: Advent International (“Advent”), one of the world’s largest and most experienced private…

Go to Top